{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:36:37Z","timestamp":1791819397211,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["24YFHZ0326"],"award-info":[{"award-number":["24YFHZ0326"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YJ202412"],"award-info":[{"award-number":["YJ202412"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["ZYYC25001"],"award-info":[{"award-number":["ZYYC25001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005153","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82370860"],"award-info":[{"award-number":["82370860"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fund for Scientific Research","doi-asserted-by":"publisher","award":["WELBIO-CR-2022 S\\u201301"],"award-info":[{"award-number":["WELBIO-CR-2022 S\\u201301"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114411","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:35:24Z","timestamp":1763537724000},"page":"114411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["An antioxidant metal-organic framework with functional coatings for oral anti-TNF-\u03b1 antibody delivery in inflammatory bowel disease treatment"],"prefix":"10.1016","volume":"389","author":[{"given":"Cheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Guilbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Marotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wunan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"Yagoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katlijn","family":"Vints","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Beloqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114411_bb0005","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/17425247.2023.2231343","article-title":"Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update","volume":"20","author":"Liu","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114411_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet, Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0015","article-title":"A review of four practice guidelines of inflammatory bowel disease","volume":"13","author":"Okobi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jconrel.2025.114411_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/flgastro-2018-101054","article-title":"Recent advances in monoclonal antibody therapy in IBD: practical issues","volume":"10","author":"Tamilarasan","year":"2019","journal-title":"Front. Gastroenterol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc3930","article-title":"Building better monoclonal antibody-based therapeutics","volume":"15","author":"Weiner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114411_bb0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114411_bb0035","article-title":"Oral delivery of biologics in inflammatory bowel disease treatment","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","article-title":"Oral delivery of macromolecular drugs: where we are after almost 100years of attempts","volume":"101","author":"Moroz","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114411_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","article-title":"Materials for oral delivery of proteins and peptides","volume":"5","author":"Brown","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114411_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115117","article-title":"Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease","volume":"203","author":"Chen","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114411_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0060","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.114411_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113079","article-title":"Pathological features-based targeted delivery strategies in IBD therapy: a mini review","volume":"151","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.114411_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2023.09.033","article-title":"Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease","volume":"363","author":"Fu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114411_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114076","article-title":"Clinical translation of advanced colonic drug delivery technologies","volume":"181","author":"Awad","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114411_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/628157","article-title":"Intestinal permeability in inflammatory bowel disease: pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut","volume":"2015","author":"Michielan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2025.114411_bb0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrgastro.2017.138","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jconrel.2020.04.006","article-title":"Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems","volume":"322","author":"Xu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114411_bb0100","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1021\/acsnano.2c09266","article-title":"Oral delivery of therapeutic antibodies with a transmucosal polymeric carrier","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114411_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.actbio.2021.12.015","article-title":"Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease","volume":"140","author":"Shrestha","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114411_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106379","article-title":"Oral infliximab nanomedicines for targeted treatment of inflammatory bowel diseases","volume":"183","author":"Mohan","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114411_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12951-020-00693-4","article-title":"Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model","volume":"18","author":"Kim","year":"2020","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118556","article-title":"Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease","volume":"273","author":"Li","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.114411_bb0125","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.apsb.2022.06.006","article-title":"Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic\/inorganic hybrid nanocomposite system","volume":"12","author":"Lee","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114411_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.136438","article-title":"Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease","volume":"445","author":"Li","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2025.114411_bb0135","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","article-title":"Nanoparticles for oral delivery: design, evaluation and state-of-the-art","volume":"240","author":"Date","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114411_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114496","article-title":"Nanoscale MOFs: from synthesis to drug delivery and theranostics applications","volume":"190","author":"Ding","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114411_bb0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2023.07.056","article-title":"Designs of metal-organic framework nanoparticles for protein delivery","volume":"361","author":"Kai","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114411_bb0150","article-title":"A valence-engineered self-cascading antioxidant nanozyme for the therapy of inflammatory bowel disease","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.114411_bb0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114411_bb0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jconrel.2021.07.002","article-title":"Recent advances and prospects of hyaluronan as a multifunctional therapeutic system","volume":"336","author":"Kotla","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114411_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.apcatb.2012.04.024","article-title":"Cu-modified cryptomelane oxide as active catalyst for CO oxidation reactions","volume":"123-124","author":"Hern\u00e1ndez","year":"2012","journal-title":"Appl. Catal. B Environ."},{"key":"10.1016\/j.jconrel.2025.114411_bb0170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2024.08.023","article-title":"An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease","volume":"374","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114411_bb0175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.carbpol.2009.04.033","article-title":"A simple method for hyaluronic acid quantification in culture broth","volume":"78","author":"Song","year":"2009","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.114411_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0003-2697(80)90492-3","article-title":"A method for the estimation of polyethylene glycol in plasma protein fractions","volume":"107","author":"Sims","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2025.114411_bb0185","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.114411_bb0190","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/nprot.2006.446","article-title":"High resolution colonoscopy in live mice","volume":"1","author":"Becker","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.114411_bb0195","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ecco-jcc\/jjy035","article-title":"Development of reliable, valid and responsive scoring Systems for Endoscopy and Histology in animal models for inflammatory bowel disease","volume":"12","author":"Koelink","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jconrel.2025.114411_bb0200","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4758","article-title":"Measuring myeloperoxidase activity as a marker of inflammation in gut tissue samples of mice and rat","volume":"13","author":"Hanning","year":"2023","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.jconrel.2025.114411_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119515","article-title":"Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis","volume":"586","author":"Huguet-Casquero","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114411_bb0210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1756-0500-6-360","article-title":"Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA","volume":"6","author":"Viennois","year":"2013","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.jconrel.2025.114411_bb0215","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1096\/fj.201701205R","article-title":"The endogenous bioactive lipid prostaglandin D(2)-glycerol ester reduces murine colitis via DP1 and PPARgamma receptors","volume":"32","author":"Alhouayek","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2025.114411_bb0220","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/ncomms8240","article-title":"Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules","volume":"6","author":"Liang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114411_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202200211","article-title":"Recent advances in mucoadhesive Interface materials, Mucoadhesion characterization, and technologies","volume":"9","author":"Bayer","year":"2022","journal-title":"Adv. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114411_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0235","first-page":"131","article-title":"Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: a multicenter study, world J Gastrointest","volume":"8","author":"Viola","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2025.114411_bb0240","first-page":"206","article-title":"A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment","volume":"32","author":"Marotti","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jconrel.2025.114411_bb0245","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","article-title":"European evidence based consensus for endoscopy in inflammatory bowel disease","volume":"7","author":"Annese","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jconrel.2025.114411_bb0250","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2025.114411_bb0255","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.7150\/thno.47601","article-title":"Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114411_bb0260","article-title":"Responsively degradable Nanoarmor-assisted super resistance and stable colonization of probiotics for enhanced inflammation-targeted delivery","volume":"36","author":"Zhu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114411_bb0265","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41565-023-01346-x","article-title":"Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis","volume":"18","author":"Cao","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114411_bb0270","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114411_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/cei.12872","article-title":"Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor alpha neutralization","volume":"187","author":"Assas","year":"2017","journal-title":"Clin. Exp. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:54:05Z","timestamp":1781326445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925010259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S0168365925010259"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114411","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An antioxidant metal-organic framework with functional coatings for oral anti-TNF-\u03b1 antibody delivery in inflammatory bowel disease treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114411"}}